Introducing the Visionary Program
We’re excited to unveil our exclusive Visionary Program, tailored for those who are eager to be at the forefront of innovation in pathology!
This program offers two distinct opportunities for our early partners to gain unique advantages with the InVision device.
Study Partners
1. Visionary Early-Adopters
The Visionary Early-Adopters program is designed for forward-thinkers ready to embrace the future of pathology. By adopting* InVision technology before the end of 2024, you will unlock limited-time pricing reductions and exclusive benefits.
As a token of our appreciation, you will also have the option to upgrade to our upcoming VisionBoard device at no additional cost, ensuring you remain on the cutting edge of technological advancements.
As a token of our appreciation, you will also have the option to upgrade to our upcoming VisionBoard device at no additional cost, ensuring you remain on the cutting edge of technological advancements.
2. Visionary Study Partners
Our Visionary Study Partners program is ideal for those who wish to integrate InVision technology into their research or clinical studies. Partners who initiate a study with InVision technology before the close of 2024 will enjoy an extended** demo period, allowing for a comprehensive evaluation of the device’s capabilities.
Additionally, this program offers subsequent pricing reductions, making it more accessible to bring this groundbreaking technology into your workflow. If you decide to upgrade to the VisionBoard in the future, you’ll have the opportunity to do so at no extra charge, keeping your practice aligned with the latest innovations.
Additionally, this program offers subsequent pricing reductions, making it more accessible to bring this groundbreaking technology into your workflow. If you decide to upgrade to the VisionBoard in the future, you’ll have the opportunity to do so at no extra charge, keeping your practice aligned with the latest innovations.
*Technology adoption is defined as the receipt of a Purchase Order (PO) before the end of 2024.
**Extended demo periods are granted upon review and approval through the CisionVision abstract review process.
Get in TouchReach out to us
for a free virtual or in-person demo
for a free virtual or in-person demo